LIVN Q1 2023 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$263M+9.7% YoY

Gross Profit

$174M66.1% margin

Operating Income

-$2M-0.9% margin

Net Income

$7M2.8% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

-4.2%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$13M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.1B

Stockholders' Equity

$1.2B

Cash & Equivalents

$523M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$263M	$240M	+9.7%
Gross Profit	$174M	$168M	+3.3%
Operating Income	-$2M	$10M	-124.6%
Net Income	$7M	$3M	+146.2%

Revenue Segments

Cardiopulmonary Segment

$132M50%

Neuromodulation Segment

$121M46%

Advanced Circulatory Support Segment

$10M4%

Geographic Segments

UNITED STATES

$140M53%

Locations Excluding The United States And Europe

$74M28%

Europe

$50M19%